Limk2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-gene
| Gene Symbol | LIMK2 |
| Full Name | LIM Domain Kinase 2 |
| Chromosomal Location | 22q12.2 |
| NCBI Gene ID | 3985 |
| Ensembl ID | ENSG00000182541 |
| UniProt ID | P53671 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease |
::
LIMK2 (LIM Domain Kinase 2) encodes a serine/threonine kinase that, like LIMK1, regulates actin cytoskeleton dynamics through phosphorylation of cofilin family proteins. While LIMK1 and LIMK2 share structural similarities, they have distinct expression patterns and functions. LIMK2 is particularly important in muscle development, brain development, and has been implicated in various neurodegenerative diseases 1.
LIMK2 is a serine/threonine kinase that:
- Phosphorylates and inactivates cofilin-1 and cofilin-2
- Regulates actin filament turnover
- Promotes actin stress fiber formation
LIMK2 contains:
- N-terminal LIM domains (2): Zinc-binding motifs for protein interactions
- PDZ domain: Postsynaptic density interactions
- C-terminal kinase domain: Catalytic activity
LIMK2 has multiple isoforms:
- LIMK2a: Full-length isoform with complete domain structure
- LIMK2b: Truncated isoform missing some N-terminal regions
LIMK2 involvement in AD:
- Cofilin regulation: LIMK2-mediated cofilin phosphorylation is altered in AD brain 2
- Actin cytoskeleton: Disrupted cytoskeletal dynamics contribute to synaptic loss
- Tau pathology: Interaction with tau phosphorylation pathways
In PD:
- Dopaminergic neurons: LIMK2 regulates cytoskeletal dynamics in dopaminergic neurons
- Alpha-synuclein: Altered expression in response to alpha-synuclein aggregation
- Mitochondrial function: LIMK2 implicated in mitochondrial dynamics
LIMK2 has been specifically implicated in HD:
- Mutant huntingtin: LIMK2 is a substrate for mutant huntingtin
- Dendritic morphology: Altered LIMK2 activity affects dendritic spine morphology
- Axonal transport: Cytoskeletal regulation impaired in HD
LIMK2 is expressed in:
- Cerebral cortex (pyramidal neurons)
- Hippocampus (CA1 region)
- Cerebellum (Purkinje cells)
- Striatum
- Substantia nigra
- Skeletal muscle (highest expression)
- Heart
- Liver
- Lung
LIMK2 represents a potential therapeutic target for neurodegenerative diseases:
- LIMK inhibitors: Small molecule inhibitors of LIMK activity are under development for various indications
- Actin remodeling: Targeting LIMK2 may help restore cytoskeletal function in neurodegeneration
- Synaptic protection: LIMK2 modulation may protect synaptic structure and function
- Biomarker potential: LIMK2 expression levels may serve as biomarkers for disease progression
- Gene therapy: Vector-mediated LIMK2 expression or inhibition approaches being explored
- Ikebe C, et al. (1998) - LIMK2: a serine/threonine kinase
- Huang TY, et al. (2019) - Cofilin in neurodegeneration
- Saitoh M, et al. (2006) - LIMK2 in cell motility
The study of Limk2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ikebe C, et al. (1998) - LIMK2: a serine/threonine kinase
- Huang TY, et al. (2019) - Cofilin in neurodegeneration
- Saitoh M, et al. (2006) - LIMK2 in cell motility